021-51111890
购物车（）
sales@molnova.cn
Substance P (5-11)
CAS No. 51165-09-4
Substance P (5-11) ( ——— )
产品货号. M40437 CAS No. 51165-09-4
Substance P (5-11) 是 Substance P (Substance P ) 的 C 端七肽 ，是一种神经肽，可以与 NK-1 速激肽受体结合。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 25MG | 获取报价 | 有现货 |
|
| 50MG | 获取报价 | 有现货 |
|
| 100MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Substance P (5-11)
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Substance P (5-11) 是 Substance P (Substance P ) 的 C 端七肽 ，是一种神经肽，可以与 NK-1 速激肽受体结合。
-
产品描述Substance P (5-11), the C-terminal heptapeptide of Substance P (Substance P ), is a neuropeptide. Substance P (5-11) binds to NK-1 tachykinin receptor.
-
体外实验———
-
体内实验When a fraction from rabbit brain enriched in glial cells was incubated with [3H]Substance P (5-11), an uptake of [3H]Substance P (5-11) is observed. When Substance P is released from nerve terminals, it is hydrolysed into Substance P (5-11), which is in turn accumulated into glial cells as well as nerve terminals and that this high affinity uptake mechanism may play an important role in terminating the synaptic action of Substance P.
-
同义词———
-
通路Others
-
靶点Other Targets
-
受体———
-
研究领域———
-
适应症———
化学信息
-
CAS Number51165-09-4
-
分子量869.06
-
分子式C41H60N10O9S
-
纯度>98% (HPLC)
-
溶解度———
-
SMILES———
-
化学全称———
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. A Inoue, et al. Active uptake system for substance P carboxy-terminal heptapeptide (5-11) into a fraction from rabbit enriched in glial cells. Jpn J Pharmacol. 1984 Oct;36(2):137-45.?
产品手册
关联产品
-
WKYMVM 2TFA(187986-1...
WKYMVM 2TFA 是一种 N-甲酰肽受体 (FPR1) 激动剂。WKYMVM 通过 FPRL1 激活中性粒细胞，而 FPRL2 是骨髓细胞中转导信号的趋化受体。使用从 28 名 AL 患者和 31 名健康对照中抽取的血液样本发现，在没有外源性 WKYMVm 的情况下，患者和对照组之间的 WKYMVm 受体和杀菌活性没有差异。
-
p2Ca
p2Ca, a naturally processed peptide that derives from a ubiquitous enzyme, alpha-ketoglutarate dehydrogenase, and is recognized in association with the class I MHC protein, Ld, by a CTL clone (2C).
-
Demethylzeylasteral
Demethylzeylasteral具有很强的免疫抑制活性，可用于器官移植和自身免疫性疾病领域。
